The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci

被引:6
作者
Itokazu, GS
Nathan, C
Hariharan, R
Kostman, JR
Kabins, SA
Weinstein, RA
机构
[1] MICHAEL REESE HOSP & MED CTR,DEPT PHARM,CHICAGO,IL 60616
[2] MICHAEL REESE HOSP & MED CTR,DEPT MED,CHICAGO,IL 60616
[3] UNIV ILLINOIS,CHICAGO,IL
[4] MT SINAI HOSP,DEPT MED,CHICAGO,IL
[5] UNIV MED & DENT NEW JERSEY,COOPER HOSP,ROBERT WOOD JOHNSON MED SCH,DIV INFECT DIS,CAMDEN,NJ 08103
关键词
clinvafloxain; in vitro activity; enterococci; vancomycin-resistant; vancomycin-susceptible;
D O I
10.1159/000239449
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The susceptibilities of 50 unique vancomycin-susceptible (n = 15) and vancomycin-resistant (n = 35) enterococci to 6 antimicrobials were compared, Teicoplanin was consistently the most active agent for all strains, Ampicillin and imipenem were active primarily for vancomycin-sensitive Enterococcus faecalis. Clinafloxacin and ciprofloxacin showed poorer activity compared to prior studies, suggesting that the emergence of quinolone resistance is now occurring in enterococci.
引用
收藏
页码:235 / 239
页数:5
相关论文
共 18 条
[1]  
BARRY AL, 1987, AM J MED, V82, P27
[2]   ACTIVITY OF CLINAFLOXACIN AGAINST MULTIDRUG-RESISTANT ENTEROCOCCUS-FAECIUM [J].
BURNEY, S ;
LANDMAN, D ;
QUALE, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (07) :1668-1670
[3]   INVITRO ACTIVITY OF RAMOPLANIN AGAINST VANCOMYCIN-RESISTANT GRAM-POSITIVE ORGANISMS [J].
COLLINS, LA ;
ELIOPOULOS, GM ;
WENNERSTEN, CB ;
FERRARO, MJ ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (06) :1364-1366
[4]   IN-VITRO ACTIVITIES OF 2 GLYCYLCYCLINES AGAINST GRAM-POSITIVE BACTERIA [J].
ELIOPOULOS, GM ;
WENNERSTEN, CB ;
COLE, G ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (03) :534-541
[5]   IDENTIFICATION OF ENTEROCOCCUS SPECIES ISOLATED FROM HUMAN INFECTIONS BY A CONVENTIONAL TEST SCHEME [J].
FACKLAM, RR ;
COLLINS, MD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (04) :731-734
[6]   MULTICENTER EVALUATION OF THE INVITRO ACTIVITIES OF 3 NEW QUINOLONES, SPARFLOXACIN, CI-960, AND PD-131,628, COMPARED WITH THE ACTIVITY OF CIPROFLOXACIN AGAINST 5,252 CLINICAL BACTERIAL ISOLATES [J].
FUCHS, PC ;
BARRY, AL ;
PFALLER, MA ;
ALLEN, SD ;
GERLACH, EH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (04) :764-766
[7]  
HARIHARAN R, 1993, PROGR ABSTR 33 INT C
[8]   INVIVO DEVELOPMENT OF TEICOPLANIN RESISTANCE IN A VANB ENTEROCOCCUS-FAECIUM ISOLATE [J].
HAYDEN, MK ;
TRENHOLME, GM ;
SCHULTZ, JE ;
SAHM, DF .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (05) :1224-1227
[9]  
KAYS M, 1993, PROGR ABSTR 33 INT C
[10]   A UNIVERSAL APPROACH TO BACTERIAL MOLECULAR EPIDEMIOLOGY BY POLYMERASE CHAIN-REACTION RIBOTYPING [J].
KOSTMAN, JR ;
ALDEN, MB ;
MAIR, M ;
EDLIND, TD ;
LIPUMA, JJ ;
STULL, TL .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (01) :204-208